INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 32 filers reported holding INMUNE BIO INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,629 | -39.1% | 4,081 | -18.3% | 0.00% | – |
| Q2 2023 | $45,346 | +45.7% | 4,994 | +3.7% | 0.00% | – |
| Q1 2023 | $31,119 | +64.3% | 4,817 | +61.2% | 0.00% | – |
| Q4 2022 | $18,944 | -97.6% | 2,988 | -97.7% | 0.00% | – |
| Q3 2022 | $800,000 | -56.5% | 129,000 | -38.1% | 0.00% | – |
| Q2 2022 | $1,841,000 | -27.2% | 208,282 | -30.7% | 0.00% | – |
| Q1 2022 | $2,530,000 | -34.5% | 300,481 | -20.6% | 0.00% | – |
| Q4 2021 | $3,861,000 | +707.7% | 378,487 | +1436.6% | 0.00% | – |
| Q3 2021 | $478,000 | +135.5% | 24,631 | +113.4% | 0.00% | – |
| Q2 2021 | $203,000 | +448.6% | 11,543 | +273.2% | 0.00% | – |
| Q1 2021 | $37,000 | +37.0% | 3,093 | +97.4% | 0.00% | – |
| Q4 2020 | $27,000 | +170.0% | 1,567 | +56.7% | 0.00% | – |
| Q3 2020 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 178,284 | $1,219,463 | 0.13% |
| Fermata Advisors, LLC | 56,702 | $383,888 | 0.11% |
| Westside Investment Management, Inc. | 41,540 | $281,227 | 0.08% |
| QUADRANT CAPITAL GROUP LLC | 60,000 | $406,200 | 0.04% |
| MAI Capital Management | 97,410 | $659,466 | 0.01% |
| Janney Montgomery Scott LLC | 256,887 | $1,739 | 0.01% |
| Financial Advocates Investment Management | 11,510 | $78,320 | 0.01% |
| VALLEY NATIONAL ADVISERS INC | 1,000 | $7 | 0.00% |
| Beacon Pointe Advisors, LLC | 10,368 | $70,191 | 0.00% |
| Asset Dedication, LLC | 814 | $6 | 0.00% |